SOCS5/6 depletion also proved to be sufficient to support xenograft tumor formation by BJT/p53KD/p16KD/ST cells in vivo, without RasV12 (Table1, Supplementary Fig S3). This evidence concerns the gene SOCS5 and neoplasm.